FIELD: biotechnology.
SUBSTANCE: present invention relates to the field of biotechnology, in particular to new synthetic polynucleotides, and can be used in medicine. The invention discloses a synthetic polynucleotide capable of binding specifically to the von Willebrand factor (VWF).
EFFECT: invention may be applicable in the preparation of a drug for the treatment of a disease, disorder or complication associated with dysfunction VWF.
50 cl, 4 dwg, 27 tbl, 24 ex
Title | Year | Author | Number |
---|---|---|---|
GLYCOSYLATED FUSED PROTEINS VWF WITH IMPROVED PHARMACOKINETICS | 2017 |
|
RU2782212C2 |
POLYPEPTIDES MODULATING SIGLEC-DEPENDENT IMMUNE RESPONSES | 2017 |
|
RU2776807C2 |
METHODS OF TREATING TTP WITH IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS AND THEIR USE | 2015 |
|
RU2807602C2 |
TREATMENT METHODS FOR HEMOPHILIA A | 2019 |
|
RU2812863C2 |
ENGINEERED PESTICIDE PROTEINS AND PLANT PEST CONTROL METHODS | 2017 |
|
RU2817591C2 |
PREPARATION CONTAINING VIII FACTOR AND VON WILLEBRAND FACTOR PEPTIDES | 2015 |
|
RU2714154C2 |
COMPOSITIONS AND METHODS FOR CONTROLLING PLANT PESTS | 2015 |
|
RU2741833C2 |
ENGINEERED PESTICIDE PROTEINS AND PLANT PEST CONTROL METHODS | 2017 |
|
RU2816526C2 |
COMPOSITIONS AND METHODS FOR CONTROLLING PLANT PESTS | 2015 |
|
RU2745322C2 |
METHODS FOR TREATMENT OF INITIAL EPISODE OF TTP USING SINGLE VARIABLE DOMAINS OF IMMUNOGLOBULINS | 2019 |
|
RU2794143C2 |
Authors
Dates
2023-11-08—Published
2018-05-18—Filed